Suppr超能文献

实验模型中药物诱导体位性低血压风险的评估:卡维地洛、哌唑嗪、拉贝洛尔和胍乙啶的研究

Evaluation of the risk for drug-induced postural hypotension in an experimental model: investigations with carvedilol, prazosin, labetalol, and guanethidine.

作者信息

Bartsch W, Sponer G, Strein K, Böhm E, Hooper R G

机构信息

Department of Experimental Cardiovascular Research, Boehringer Mannheim GmbH, F.R.G.

出版信息

J Cardiovasc Pharmacol. 1987;10 Suppl 11:S49-51.

PMID:2454367
Abstract

Postural hypotension is a common side effect observed in the treatment of hypertension with various drugs. Carvedilol, a vasodilating beta-blocker, was compared with prazosin, labetalol, and guanethidine for its ability to induce orthostatic hypotension. The comparison was carried out using doses of the drugs required to lower baroreceptor reflex hypertension in anesthetized rabbits by 30 mm Hg (ED -30 mm Hg). The following doses were found in independent investigations to be equipotent in this rabbit model: ED -30 mm Hg (mg/kg i.v.): prazosin = 0.03; labetalol = 1.8; guanethidine = 0.12; carvedilol = 0.12. These doses did not markedly inhibit the orthostatic reaction in rabbits after tilting stress, so 10-fold higher doses were used and clear discrimination between the drugs was found. The orthostatic index was reduced after prazosin and labetalol by about 24%, after guanethidine by about 30%, and after carvedilol by about 13%. The 50-fold dose of carvedilol (6 mg/kg i.v.) does not lead to any greater inhibition of the orthostatic index. From these results it is concluded that a relatively lower risk of postural hypotension is to be expected after carvedilol treatment than with the other drugs presented here. Furthermore, these results do not provide any indication that carvedilol exerts its vasodilator properties via alpha-blockade.

摘要

体位性低血压是使用各种药物治疗高血压时常见的副作用。将血管舒张性β受体阻滞剂卡维地洛与哌唑嗪、拉贝洛尔和胍乙啶诱导体位性低血压的能力进行了比较。比较是使用在麻醉兔中使压力感受器反射性高血压降低30 mmHg(ED -30 mmHg)所需的药物剂量进行的。在独立研究中发现以下剂量在该兔模型中具有等效性:ED -30 mmHg(静脉注射mg/kg):哌唑嗪=0.03;拉贝洛尔=1.8;胍乙啶=0.12;卡维地洛=0.12。这些剂量在倾斜应激后并未明显抑制兔的体位反应,因此使用了高10倍的剂量,发现药物之间有明显差异。哌唑嗪和拉贝洛尔使体位指数降低约24%,胍乙啶使体位指数降低约30%,卡维地洛使体位指数降低约13%。卡维地洛50倍剂量(静脉注射6 mg/kg)并未导致体位指数有更大程度的抑制。从这些结果可以得出结论,与这里介绍的其他药物相比,预计卡维地洛治疗后体位性低血压的风险相对较低。此外,这些结果并未表明卡维地洛通过α受体阻滞发挥其血管舒张特性。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验